In this case, we showed that pembrolizumab combined with 5-fluorouracil and cisplatin therapy was effective for p16-positive squamous cell carcinoma, as the treatment rapidly reduced the tumor volume. The gene discussed is CDKN2A; the disease is neoplasm.